✦ LIBER ✦

Erratum to: Trastuzumab: a review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer

✍ Scribed by KP Garnock-Jones, GM Keating, LJ Scott

Book ID: 119931309
Publisher: Springer International Publishing AG
Year: 2011
Tongue: English
Weight: 49 KB
Volume: 71
Category: Article
ISSN: 0012-6667
DOI: 10.2165/11596220-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human Epidermal Growth Factor Receptor 2

Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Relapsing Post-Adjuvant Trastuzumab: Pattern of Recurrence, Treatment and Outcome

✍ Jonathan Krell; Colin R. James; Deep Shah; Ondrej Gojis; Adrian Lim; Pippa Riddl 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 371 KB

Use of adjuvant trastuzumab in women wit

Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network

✍ Rachel A. Freedman; Melissa E. Hughes; Rebecca A. Ottesen; Jane C. Weeks; Yulei 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

PCN158 Adherence to Human Epidermal Grow

PCN158 Adherence to Human Epidermal Growth Factor Receptor-2 (HER2) Testing & Adjuvant Trastuzumab Treatment Guidelines in a Canadian Province

✍ I.L. Ferrusi; M. Trudeau; C.C. Earle; N. Leighl; E. Pullenayegum; H. Khong; J. H 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Value of serum human epidermal growth fa

Value of serum human epidermal growth factor receptor 2 (HER2)/neu testing in breast cancer patients to maximize detection of her2/neu-positive patients and susceptability to Trastuzumab

✍ Fani Pakdel Azar; Homayy Shandiz Fatemeh 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Ado-trastuzumab emtansine (T-DM1) in hum

Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential

✍ Peddi, P. F.; Hurvitz, S. A. 📂 Article 📅 2014 🏛 SAGE Publications 🌐 English ⚖ 425 KB

Phase II Study of the Antibody Drug Conj

Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) -Positive Breast Cancer After Prior HER2-Directed Therapy

✍ Burris, H. A.; Rugo, H. S.; Vukelja, S. J.; Vogel, C. L.; Borson, R. A.; Limenta 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 176 KB